Star Health Insurance has published the audited standalone financial results for the quarter and year ended March 31, 2026 in Business Standard (English Edition) and Dinamani (Tamil Edition) newspapers, complying with Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The notification, dated April 30, 2026, was submitted to BSE Limited and National Stock Exchange of India Limited under reference number SHAI/B & S/SE/17/2026-27.

Financial Results Summary

The health insurer reported total income from operations of ₹18,62,192 lakhs for the year ended March 31, 2026, compared to ₹16,78,136 lakhs in the previous year. For the quarter ended March 31, 2026, total income from operations stood at ₹5,96,840 lakhs against ₹5,13,801 lakhs in the corresponding period of the previous year.

Quarterly Performance

For the three months ended March 31, 2026, the company recorded a net profit after tax of ₹11,134 lakhs, a significant improvement from ₹51 lakhs in the same quarter of the previous year. The net profit before tax stood at ₹15,121 lakhs compared to a loss of ₹87 lakhs in Q4 FY25.

Corporate Governance and Compliance

The financial results were reviewed by the Audit Committee and approved by the Board of Directors in their meeting held on April 28, 2026. The Joint Statutory Auditors have audited the results. The disclosure was digitally signed by Jayashree Sethuraman, Company Secretary & Compliance Officer, ensuring compliance with stock exchange listing requirements. The complete financial results are available on the company's website at www.starhealth.in and on the stock exchange websites.

Star Health and Allied Insurance Company Limited announced that its Board of Directors has approved an amended Policy on Insider Trading on April 28, 2026. The policy amendment was undertaken in compliance with Regulation 8(2) of the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015.

Policy Overview and Compliance Framework

The amended policy serves as a comprehensive framework to prevent insider trading by regulating communication, procurement, and dealing in unpublished price sensitive information (UPSI). The policy functions as a Code of Conduct to regulate, monitor, and report trading by designated persons within the organization.

Key Policy Components

The policy encompasses three integral components that work together to ensure comprehensive compliance:

• Code of Practices and Procedures for Fair Disclosure of UPSI
• Policy and Procedures for Inquiry in case of Leak of UPSI or Suspected Leak of UPSI
• Trading regulations and pre-clearance mechanisms

Trading Window and Pre-clearance Requirements

The policy establishes specific trading windows during which designated persons may trade in the company's securities after securing pre-clearance. The trading window remains closed from the first day following each calendar quarter until 48 hours after disclosure of quarterly or annual financial results to stock exchanges.

Roles and Responsibilities

The policy clearly defines roles across different organizational levels. The Board of Directors specifies designated persons and ensures adequate internal control systems. The Chief Executive Officer/Managing Director implements effective compliance systems, while the Company Secretary serves as the Compliance Officer responsible for maintaining designated person lists, granting pre-clearance approvals, and monitoring trading activities.

Penalty Provisions and Enforcement

Violations of the policy result in structured penalties, with warning letters for first-time violations and monetary penalties up to 25% of transaction profits for subsequent violations. The Compliance Officer must inform stock exchanges of all policy violations within 48 hours. Penalty amounts collected are remitted to the SEBI Investors Education and Protection Fund.

The policy has been made available on the company's website at www.starhealth.in and will remain effective from the date of approval by the Board of Directors.